We have previously observed that Wnt signaling activates a fibrogenic program in adult muscle stem cells, called satellite cells, during aging. We genetically labeled satellite cells in a mouse model of Duchenne muscular dystrophy to follow their fate during the progression of the disease. We observed that a fraction of satellite cells had a reduced myogenic potential and showed enhanced expression of profibrotic genes compared to age-matched controls. By combining in vitro and in vivo results, we found that expression of transforming growth factor-b2 (TGFb2) was induced in response to elevated canonical Wnt signaling in dystrophic muscles and that the resulting increase in TGFb activity affected the behavior of satellite cells in an autocrine or paracrine fashion. Indeed, pharmacological inhibition of the TGFb pathway in vivo reduced the fibrogenic characteristics of satellite cells. These studies shed new light on the cellular and molecular mechanisms responsible for stem cell dysfunction in dystrophic muscle and may contribute to the development of more effective and specific therapeutic approaches for the prevention of muscle fibrosis.
INTRODUCTION
Satellite cells represent a muscle-specific stem cell population that is responsible for adult skeletal muscle regeneration (1) (2) (3) . In healthy muscles, satellite cells are maintained in a quiescent state and are juxtaposed close to the surface of the myofibers and beneath the basal lamina that surrounds each fiber (4) . In response to muscle damage, satellite cells exit the quiescent state and begin to proliferate. Their progeny either differentiate and fuse into newly regenerated muscle fibers or renew the pool of satellite cells by becoming quiescent again (2) . Quiescent satellite cells express Pax7, but undetectable amounts of the myogenic regulatory factor MyoD (3) . Upon activation, the satellite cells rapidly express MyoD and subsequently myogenin before undergoing terminal differentiation (3) . Recent cell ablation studies have demonstrated that muscle regeneration is abrogated in the absence of Pax7 +ve satellite cells (5, 6) . Duchenne muscular dystrophy (DMD) is the most common inherited muscle disease of childhood (7) . DMD is caused by mutations in the gene encoding the sarcolemmal protein dystrophin (8) . In the absence of dystrophin, myofibers are particularly prone to degeneration, leading to repetitive rounds of fiber degeneration and regeneration (9) . Over time, the regenerative ability of dystrophic muscles becomes impaired, and fibrotic tissue replaces the myofibers, leading to a severe reduction in muscle function (9) . The cellular and molecular bases for the defective regenerative potential seen in the advanced stages of DMD are still largely unexplored (9, 10) . Moreover, although there is evidence of an involvement of macrophages and T cells and a role for different members of the transforming growth factor-b (TGFb) superfamily in the etiology of fibrosis, determinants of the accumulation of fibrotic tissue in dystrophic muscles remain poorly defined (11) .
Defective regeneration and accumulation of fibrotic tissue also characterize aging muscle. Previous work from our laboratory has shown that a fraction of satellite cells isolated from aged muscle convert from a myogenic to a fibrogenic lineage in a Wnt-dependent manner and that this accounts in part for the declining regenerative potential of muscle with age (12) . Given the even greater disruption of regenerative potential in dystrophic muscle, we hypothesized that the dystrophic setting could also affect the fate of satellite cells. This idea is supported by the observation that satellite cells obtained from mdx mice (a model of DMD) (13) or cultured from muscles of DMD patients are more likely to produce increased amounts of extracellular matrix (ECM) proteins compared to control satellite cells (14, 15) . However, whether satellite cells undergo a conversion to an alternate lineage in the dystrophic environment in vivo is not known. Such a conversion would certainly have a negative impact on the efficacy of muscle regeneration.
Using an in vivo genetic lineage tracing strategy relying on the Cre/loxP system, we observed that a fraction of satellite cells in the mdx mouse lose their ability to follow a myogenic program and show increased expression of fibrotic genes. We present data suggesting a causal link between the canonical Wnt and TGFb2 pathways, activation of which lead to the induction of fibrogenic features in satellite cells in dystrophic muscles and potentially to increased tissue fibrosis.
RESULTS

A fraction of satellite cells show an aberrant lineage decision in dystrophic mice
We have previously shown that the aging environment induces fibrogenic features in satellite cells (12) . To evaluate if the fate of satellite cells is similarly affected by the dystrophic muscle environment, we traced the fate of satellite cells using the Pax7 CreER ;R26R
YFP mouse strain. In this strain, CreER is knocked into the Pax7 locus, and the administration of tamoxifen (TMX) allows the fate of satellite cell progeny to be monitored through genetic lineage tracing using the yellow fluorescent protein (YFP) reporter gene ( fig. S1A ). We bred this strain with the mdx 5Cv mouse model of DMD (16) . Eleven months after TMX treatment, we evaluated satellite cells and their progeny (YFP +ve ) for their myogenic potential. Sections from diaphragm, a muscle that is severely affected in mdx mice (17) , were stained with antibodies recognizing YFP and the myogenic cell markers Pax7, MyoD, and myogenin. All of the myogenic markers were undetectable in a fraction (ranging from 7 to 20%) of YFP +ve cells in mdx 5Cv diaphragms, whereas nearly all (>98%) of the YFP +ve cells from wildtype (WT) age-matched controls expressed one or more of the myogenic markers (Fig. 1A) . The analysis of diaphragm satellite cells in vitro confirmed this observation ( fig. S1B ). We observed an increase in the expression of Col1a1, Fn1, and other well-known fibrotic genes in YFP +ve cells purified by fluorescenceactivated cell sorting (FACS) from mdx 5Cv mice (Fig. 1B and fig. S1 , C and D). An increase in the expression of Col1a1 and Fn1 and a decrease in the expression of the myogenic marker MyoD were confirmed when satellite cells were allowed to expand in vitro ( fig. S1E ). Moreover, Pax7/MyoD/myogenin −ve cells exhibited an increase in the intensity of staining for the collagen-specific molecular chaperone heat shock protein 47 (HSP47) (18, 19) (Fig. 1C) . In diaphragms from mdx 5Cv mice, a fraction of the YFP +ve cells were observed outside of its typical position (which is juxtaposed to the fiber beneath the basal lamina), with almost one-third of this cell fraction expressing HSP47 and surrounded by basal lamina (Fig. 1D and fig. S2A ). The localization of satellite cells or their progeny in the interstitium was also confirmed using a LacZ-expressing reporter strain ( fig.  S2B ). In contrast, only a small fraction (∼4%) of satellite cell progeny was not juxtaposed to myofibers in age-matched WT mouse muscle ( Fig. 1D and fig. S2C ). Altogether, these observations suggest that during the progression of dystrophic disease, the progeny of satellite cells display a defective myogenic program and adopt a fibrogenic phenotype, both in terms of gene expression and anatomical localization. These changes would be expected to impair muscle regenerative potential and potentially contribute to the accumulation of ECM in the muscle interstitium.
Canonical Wnt signaling is elevated in mdx mouse muscles A critical molecular determinant of the fibrogenic conversion of satellite cells in the aged environment is the presence of factors that lead to enhanced Wnt signaling in the cells (12, 20) . Moreover, a recent report has implicated increased Wnt signaling in the proliferation of stromal cells in mdx mouse muscle (21) . With the aim to explore the Wnt pathway in more detail, we bred the Wnt reporter BAT-GAL mice onto the mdx 5Cv background. Increased Wnt signaling, reflected by increased b-galactosidase (b-Gal) activity, was not homogeneous but was patchy, as has been described for the pattern of degeneration and regeneration in dystrophic muscle (22) (Fig. 2A) . A similar patchy distribution of the canonical Wnt signaling pathway effector b-catenin (23) was confirmed by immunofluorescence (Fig. 2B) (26, 27) . Quantitative RT-PCR revealed that, similar to Axin2, TGFb2 was induced by canonical Wnt3a but not by noncanonical Wnt5a (Fig. 3A and fig. S3A ). Primary myoblasts and YFP +ve cells isolated from dystrophic and WT mouse muscles displayed a strong Wnt3a-dependent induction of TGFb2 expression (Fig. 3, A and B, and fig. S3 , A and B). To further demonstrate that the Wnt-dependent induction of TGFb2 expression occurred through the canonical Wnt pathway, we treated myoblasts with the GSK-3b (glycogen synthase kinase3b) inhibitor BIO to activate the Wnt pathway. Induction of both Axin2 and TGFb2 expression was observed ( Fig.  3C and fig. S3C ). In contrast, the addition of the tankyrase inhibitor XAV-939 at a concentration that could effectively block Wnt signaling markedly reduced the induction of TGFb2 and Axin2 by Wnt3a in WT myoblasts (Fig. 3D and fig. S3 , D and E). The induction of TGFb2 by the canonical Wnt pathway was further confirmed by the overexpression of a stabilized form of b-catenin (28) (Fig. 3E and  fig. S3F ). Expression of the canonical Wnt signaling effector Bcl9l potentiated the action of b-catenin on TGFb2 expression, whereas a mutant form, missing the C-terminal domain (29) , was unable to induce the same effect ( Fig. 3E and fig. S3 , F and G). Several potential Wnt-responsive elements characterized by the T cell factor/lymphoid enhancer factor (TCF/LEF) binding consensus sequence were noted in the regulatory regions upstream and downstream of the transcription start site of the mouse Tgfb2 gene ( fig. S4A ). Chromatin immunoprecipitation (ChIP) assays with an antibody recognizing b-catenin confirmed its binding to a region in the first intron of Tgfb2, about 2000 base pairs downstream of the transcription start site ( fig. S4B ). This evidence, together with the rapid kinetics of induction of TGFb2 by Wnt3a, suggests that TGFb2 could be a direct target of canonical Wnt signaling. cultures, without affecting the expression of the Wnt target gene Axin2 (Fig.  4E and fig. S6, C and D) . These loss-offunction approaches indicate a functional hierarchical relationship between canonical Wnt and TGFb2-mediated signaling. These observations suggest that canonical Wnt signaling can induce the expression and secretion of TGFb2, which promotes the acquisition of fibrogenic features by cells previously in the myogenic lineage. To further corroborate this model, we overexpressed stabilized b-catenin in myoblasts, collected the medium after 24 hours, and treated cultures of myogenic cells with this conditioned medium. We consistently observed an increase in Col1a1 expression in cultures treated with the conditioned medium from cells transfected with a b-catenin expression vector compared to cells transfected with a control vector (Fig. 4F) . The addition of a TGFb2-specific blocking antibody counteracted the effect of the conditioned medium (Fig. 4F) . A similar increase in Col1a1 expression was also observed upon transfection with a plasmid expressing TGFb2 or by addition of recombinant TGFb2 (Fig. 4F and fig. S6D ). These in vitro observations indicate that activation of the Wnt-TGFb2 axis can alter satellite cell state.
TGFb2 expression is elevated in mdx muscles
Although several studies have evaluated the expression of TGFb1 in dystrophic muscle (31, 32) , there is little evidence of TGFb2 expression in relation to the pathogenesis of muscular dystrophies (33) . We therefore characterized the expression of TGFb2 and its relation to canonical Wnt signaling in muscles of mdx 5Cv mice. The amounts of both dephosphorylated (stabilized) b-catenin and TGFb2 were increased in diaphragm muscles from mdx 5Cv mice when compared to age-matched controls (Fig. 5A) . In particular, the regenerative foci in mdx 5Cv muscles, which are characterized by the expression of embryonic myosin heavy chain (eMyHC), stained strongly for TGFb2 (Fig. 5B and fig. S7A ), consistent with an observation in muscles of DMD patients (34) ;mdx 5Cv mice in comparison to age-matched WT control mice (Fig. 5C and fig. S7B ). With the aim of comparing the pattern of Wnt signaling with the pattern of TGFb2 expression, we costained muscles from mdx 5Cv mice with antibodies recognizing TGFb2 and Axin2, bcatenin, or LGR5 (Fig. 5D and fig. S7, C and D) . The regions of muscles that were characterized by strong expression of Axin2, b-catenin, or LGR5 also exhibited strong staining for TGFb2. These data demonstrate a correlation between elevated Wnt signaling and elevated TGFb2 signaling, consistent with the data demonstrating the induction of TGFb2 by canonical Wnt signaling.
In vivo inhibition of the TGFb pathway rescues the satellite cell phenotype These observations, together with the role of TGFb2 as a downstream mediator of the effects of Wnt signaling in the control of satellite cell fate, suggest that inhibiting TGFb signaling might be a way to counteract the aberrant behavior of satellite cells in muscles of mdx mice. To test this possibility, we first treated Pax7 CreER ;R26R YFP ;mdx 5Cv mice for 7 months with losartan, a drug that not only is approved for use in humans but also has been shown to efficiently antagonize TGFb signaling in mdx mice (35) . We observed a general reduction in the expression of the fibrotic gene HSP47 and in the abundance of phosphorylated SMAD2/3 (pSMAD2/3), a readout of TGFb signaling, in response to losartan treatment ( fig. S8A) mice treated with losartan (Fig. 6A) . In addition to reducing the induction of fibrotic markers in satellite cells, the administration of losartan partially preserved the myogenic program in satellite cells in mdx 5Cv mice (Fig. 6B) . In keeping with this observation, we noted an increase (not statistically significant) in the expression of the myogenic markers Pax7 and MyoD after treatment with losartan in vivo (Fig. 6C) . Similar results to those obtained with losartan were obtained after treating dystrophic mice for 6 months with an anti-TGFb antibody (Fig. 6, A to C) . In agreement with previous reports (35) (36) (37) , blocking the TGFb signaling pathway in vivo partially ameliorated the dystrophic phenotype ( fig. S9,  A and B) . These data support the notion that enhanced TGFb signaling induces both an aberrant behavior in satellite cells and the accumulation of fibrotic tissue in dystrophic muscles.
DISCUSSION
Here, we present direct evidence that satellite cells have a compromised myogenic potential and enhanced expression of fibrogenic genes in the dystrophic muscles of mdx mice. Our data link enhanced Wnt signaling with a local increase in the expression of TGFb2 in dystrophic muscles and suggest that the resulting increase in TGFb activity is responsible for the induction of fibrogenic features in satellite cells induced by the canonical Wnt signaling pathway (Fig. 6D) .
These observations support the notion that aberrant behavior of cells in the satellite cell lineage is actively contributing to the dystrophic phenotype, both indirectly by giving rise to a population that less effectively promotes regeneration and directly by producing components of the ECM. In keeping with this view, the pharmacological inhibition of TGFb signaling both counteracted the fibrogenic activity of satellite cells and reduced the accumulation of fibrotic tissue within the dystrophic muscles. These data do not exclude the possibility that the improved characteristics of the satellite cells in response to inhibition of TGFb signaling may also be a consequence of the amelioration of the dystrophic phenotype. Nevertheless, the concept that the severity of the dystrophic condition is dependent on the behavior of satellite cells is supported by irradiation studies and by the observation that the severity of the muscular dystrophy in mdx mice is worsened when crossed with a mouse strain in which satellite cell self-renewal is impaired (38, 39) . Moreover, several studies in which genes important for the function of the satellite cells have been genetically ablated in mdx mice also documented a worsening of the dystrophic phenotype (40) (41) (42) . Satellite cells isolated from mdx mice or DMD patients have been reported to exhibit abnormalities in vitro, including decreased clonogenic ability, defective expansion, prolonged doubling times, abnormal differentiation, delayed fusion, altered morphology, presence of crystalline perinuclear inclusions, and reduction in angiogenesis-promoting activity (14, 15, (43) (44) (45) (46) (47) (48) (49) (50) . Although these studies demonstrate that aberrant function of satellite cells from dystrophic muscle persists during culture in vitro, our study explores the consequences of aberrant satellite cell characteristics in vivo using lineage tracing to track the fate of the satellite cells in dystrophic muscle.
The idea that the progeny of the satellite cells could directly contribute to the accumulation of fibrotic tissue in dystrophic muscles is supported by the observation that a fraction of the mdx satellite cell progeny showed an increased expression of components of the ECM. We observed the presence of satellite cells or their progeny in the interstitium of dystrophic muscle, and we found that these cells expressed generally higher amounts of the profibrotic, collagen-specific processing enzyme HSP47. These observations extend previous electron microscopic observations of satellite cells displaced from myofibers in muscles of DMD patients (51). It is not clear if the aberrant localization of a fraction of the satellite cells depends on the alterations in the architecture of the diseased muscle or reflects intrinsic changes in the satellite cell progeny themselves. Although correlative, the observation of an enhanced expression of TGFb2 in the regenerative foci of the mdx muscles is suggestive that satellite cells could acquire a fibrogenic potential during the process of regeneration, when a remodeling of the basal lamina is occurring (52) .
Although the body of evidence presented here supports an active role of satellite cells in the production of ECM in dystrophic muscles, it does not suggest that satellite cell progeny are the primary source of ECM proteins. Several cell types, including fibroblasts, pericytes, and Sca +ve resident mesenchymal cells, have been proposed as sources of ECM proteins in the context of muscle diseases and regeneration (21, (53) (54) (55) (56) (57) . The possibility that different cell types could be involved in the abnormal deposition of components of the ECM in the dystrophic setting parallels observations of fibrotic diseases affecting other tissues, such as liver, lung, and kidney, in which different cellular components have been shown to contribute to the etiology of fibrosis (58) (59) (60) (61) (62) (63) (64) . Recently, an elegant study used newly developed genetic tools to evaluate the relative contribution of distinct lineages to the fibrotic process in the context of kidney fibrosis (65) .
Data presented here highlight previously unappreciated similarities in the behavior of satellite cells in the context of muscular dystrophy and aging, two conditions characterized by defective regenerative potential, chronic inflammation, and fibrosis (11) . We show that both aging and dystrophic muscles are characterized by increased Wnt signaling and alterations in stem cell fate (12) . It is therefore possible that the molecular events we observed in dystrophic muscles could be relevant to abnormalities of aging muscles as well. We are currently exploring the possibility that TGFb2 could play a detrimental role in the context of muscle aging and other conditions characterized by increased Wnt signaling and stem cell dysfunction (23) .
Our data support a key role of a Wnt-TGFb2 axis in controlling the behavior of satellite cells in dystrophic muscles. These observations place the canonical Wnt signaling pathway and the TGFb2 pathway in central positions in the complex network of signals that are altered in dystrophic muscles and that have been implicated in the etiology of fibrosis (11) . An interaction between Wnt and TGFb signaling pathways has been described in several physiological and pathophysiological conditions. During cardiac and somite development, Wnt11 can induce TGFb2 through a noncanonical ATF (activating transcription factor)/ CREB (adenosine 3′,5′-monophosphate response element-binding protein)-dependent mechanism, and recent work investigating kidney development and the molecular changes associated with renal dysplasia supports a link between TGFb2 expression and canonical Wnt signaling (66, 67) . Our data suggest that a canonical Wnt-TGFb2 axis could be operative in a distinct pathophysiological process in muscle. An increasing body of evidence not only supports the idea that Wnt signaling can modulate TGFb signaling at different levels (68-70) but also suggests that TGFb may positively regulate canonical Wnt signaling (71) (72) (73) (74) . In particular, the recent observation that Wnt signaling is required for TGFbmediated fibrosis in an animal model of skin fibrosis (75) , together with our identification of a Wnt-TGFb2 axis in dystrophic muscles, suggests the possibility that an autoreinforcing loop could result from the crosstalk between the Wnt and TGFb2 signaling pathways. Such a loop would amplify the events downstream of Wnt and TGFb and could play an important role in the etiology of fibrosis in muscle and in other tissues.
Several members of the TGFb superfamily have been previously implicated in DMD pathogenesis (31, 35, 36, 76, 77) , but the specific role exerted by each member in determining the enhanced TGFb signaling observed in dystrophic muscle remains uncertain. We propose that TGFb2 may be a key player in this context. Intriguingly, it has been described that active TGFb signaling can induce an autocrine expression of TGFb1 in myogenic cells, and the overexpression of this cytokine may exert a profibrotic action on muscle cells (78) . Because the approaches used in this study to interfere with TGFb signaling in vivo do not discriminate between TGFb1 and TGFb2, it will be of particular interest to define to what extent TGFb1 is cooperating with TGFb2 in activating TGFb signaling in general and altering the state of the satellite cells in the dystrophic muscles. Our observations also raise additional questions that relate to fibrosis in dystrophic muscle and perhaps even more generally. An increased presence of Wnt ligands and receptors and a decreased expression of inhibitors of the Wnt pathway have been proposed to be responsible for the enhanced Wnt signaling reported in aging tissues (79) (80) (81) (82) . In the case of dystrophic muscle, the cause of the enhanced Wnt signaling is unknown. Also unknown is whether the increase in TGFb2 expression observed in dystrophic muscles depends exclusively on the enhanced Wnt signaling or whether other molecular pathways are also playing a role in this process. Another important question that derives from our findings is whether the Wnt-TGFb2 axis is affecting the behavior of other cell types besides satellite cells and to what extent these effects play a role in the etiology of fibrosis. Moreover, the molecular events that are operating downstream of TGFb2 signaling and are mediating its profibrotic effects also remain largely unknown. Future studies will be important to provide a comprehensive view of the events leading to defective regeneration and excessive fibrosis that ultimately result in compromised functionality of dystrophic muscles.
In conclusion, the observations reported here increase our understanding of local and systemic changes that may affect stem cells in the setting of chronic, degenerative conditions and suggest that aberrant stem cell function could contribute to the development of fibrosis in the muscular dystrophies. Fibrosis is prominent, either as a primary process or as a secondary process, in a variety of degenerative and inflammatory diseases (83) . Fibrosis itself both contributes to the symptomatology of such diseases and is also a barrier to effective therapies (84) . Therefore, this study, by increasing our understanding of the cellular and molecular mechanisms leading to fibrosis, represents an important step toward the development of effective therapeutic approaches for the treatment of fibrosis in the setting of degenerative disorders of muscle and other tissues (26) .
MATERIALS AND METHODS
Study design
The overall objective of this study was to evaluate the fate of satellite cells during the progression of muscular dystrophy by analyzing mdx 5Cv mice and comparing them with age-matched WT controls or by analyzing mdx 5Cv mice after inhibition of the TGFb signaling pathway. An additional aim of the study was to investigate the link between Wnt signaling and the expression of TGFb2 and to evaluate the WntTGFb2 axis as a regulator of satellite cell behavior. Preliminary data and similar studies previously performed with cells and tissues collected from aging mice indicated that three to seven biological replicates per animal were required in each group to detect a 20% difference in the amounts of gene expression in satellite cells with power of 0.8 and significance level of 0.05. Animals were randomly assigned to experimental and treatment groups based on availability and genotype. No animals were excluded from analysis. With the exception of the microarray analysis and the experiments reported in Figs. 1 (A and D) YFP/WT males. These breeders were crossed with mdx 5Cv/5Cv or WT female (both in the C57BL6 background, The Jackson Laboratory) to obtain the male experimental animals. TMX (Sigma) was dissolved at 50 mg/ml in 92.5% corn oil/7.5% ethanol, and 5 mg was administrated intraperitoneally to 5-week-old experimental mice twice a week for 2 weeks. For specific experiments, R26R LacZ mice were used (The Jackson Laboratory, no. 003474). BAT-GAL mice (The Jackson Laboratory, no. 005317) are engineered with copies of the Wnt-inducible TCF/LEF-responsive element driving the expression of b-Gal. Genotyping was performed with primers listed in table S2.
In chronic studies, mdx5 Cv mice were injected with 300 ng of antiTGFb (1D11) or anti-Shigella toxin (control) antibodies on alternate days for 6 months (36). Purified antibodies were provided by Genzyme (37) . Losartan was administrated for 7 months (0.6 g/liter in drinking water) (35) . Treatments were started at 5 weeks of age. Experiments were done in accordance with protocols approved by the Institutional Animal Care and Use Committee at the Veterinary Medical Unit at the VA Palo Alto Health Care System.
Real-time PCR
RNA was extracted using TRIzol (Invitrogen) and was reverse-transcribed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Quantitative RT-PCR was carried out on a LightCycler 480II thermocycler (Roche) with LightC480 Probe master or SYBR Green I Master kits (Roche). For SYBR Green assays, primers annealing to different exons were used (table S3) . Unless otherwise stated, relative quantification was normalized to mouse HPRT (hypoxanthine-guanine phosphoribosyltransferase). For TaqMan assays, Pax7, MyoD, and GAPDH (glyceraldehyde phosphate dehydrogenase) (normalizer) probes were used (Applied Biosystems).
Immunofluorescence Cells were processed for immunofluorescence, as previously described (86) . For immunofluorescence studies, muscles were fixed for 4 hours using 0.5% electron microscopy-grade paraformaldehyde and transferred to 20% sucrose overnight. Muscles were then frozen in optimum cutting temperature compound (OCT) (Tissue-Tek), cryosectioned at 6 mm, and stained using indirect immunofluorescence or the Zenon labeling kit (Invitrogen). Alexa Fluor 488/594/647 donkey secondary antibodies (Invitrogen) were used. SMAD2/3 immunostaining required additional treatment with 4 N HCl (87) . A list of primary antibodies is enclosed in table S4.
Pixel intensity was calculated with Volocity Analysis Software (PerkinElmer). For HSP47 and Collagen1, the maximal pixel intensity was evaluated for each cell. Background intensity of areas devoid of cells was subtracted. For the evaluation of b-catenin, TGFb2, and Collagen1/3 in WT and mdx 5Cv muscle sections, the average pixel intensity of multiple (>8) selected areas was quantified. The background pixel intensity from serial sections stained with only the secondary antibodies was subtracted. Experiments were done in at least three biological replicates. For the correlation between the expression of TGFb2 and the Wnt-related genes Axin2, LGR5, or b-catenin in mdx 5Cv muscles, 120 areas (40 for each mouse; three mice) of 25 mm 2 were randomly selected in at least nine different sections, and the corresponding average pixel intensities were quantified. The background pixel intensity from sections stained with only the secondary antibodies was subtracted. Linear regression and correlation (Pearson r) were determined with GraphPad Prism 6.04 software.
X-gal staining
For X-gal staining, sections (10 mM) were incubated for 1 day in X-gal solution. For whole-mount X-gal staining, muscles were fixed for 5 hours in 0.5% paraformaldehyde and incubated for 3 days at 37°C in X-gal solution, as previously described (86) .
Cell isolation and culture
To obtain mononucleated cells, adult hindlimb or diaphragm muscles were processed, as previously described (86) . For immunostaining with anti-YFP, anti-Pax7, anti-MyoD, anti-myogenin, and anti-HSP47 antibodies, cells isolated from muscles were resuspended in Ham's F-10 nutrient mixture supplemented with 10% horse serum (HS) (Invitrogen). Unless otherwise stated, cells were allowed to adhere overnight on ECM-coated slides (BioCoat, BD) before fixation. To test the effects of Wnt3a and TGFb2, we added these factors to fresh medium the day after plating and renewed every day.
For RT-PCR, YFP +ve cells from Pax7
CreER ;R26R YFP mice (WT or mdx5 Cv ) were further purified using a FACSAria III (BD). Mice without the R26R YFP allele were used to set up the autofluorescence. DAPI dilactate (250 mg/ml, Invitrogen) was used to exclude dead cells. When indicated, satellite cells were purified by positive selection with an antivascular cell adhesion molecule antibody (BD Biosciences) and negative selection (Lin −ve ) with antibodies recognizing CD31, CD45 (BD Biosciences), and Sca1 (BioLegend), as previously described (86) . Cells were processed for RNA extraction after sorting or after 4 days in vitro. When indicated, Wnt3a (100 ng/ml) was added for the last 30 hours.
Primary myoblasts were isolated from 129 (Charles River) or C57 (The Jackson Laboratory) mice, as previously described (88) . Cells were cultured on laminin/collagen-coated wells in Ham's F-10 with 20% fetal bovine serum (FBS) and basic fibroblast growth factor (2.5 ng/ml) (Promega) or Dulbecco's modified Eagle's medium (DMEM) with 2% HS to maintain them in a proliferative state or to induce differentiation, respectively.
C2C12 myoblasts [American Type Culture Collection (ATCC)] were expanded in DMEM with 10% FBS. In fate conversion assays, C2C12 myoblasts were maintained in DMEM with 2% HS for 2 days in the presence of indicated factors. Cells were trypsinized [trypsin-EDTA (0.05%)] until complete detachment, filtered through 40-mm strainers to eliminated myotubes, and replated for 2 hours. The kinetics of detachment and adhesion was monitored by time lapse microscopy. In experiments with conditioned medium, C2C12 were cultured in sixwell dishes in 800 ml of Ham's F-10 with 10% HS for 24 hours. The medium was filtered through 0.22-mm filters and added to primary myoblasts for 24 hours.
In specific experiments, LSL cells were used to evaluate Wnt activity (89) . They were cultured in DMEM with 10% FBS for 24 hours in the presence of XAV-939. Wnt3a was added for 8 hours, and cells were processed to assay luciferase activity (Promega).
Reagents
Reagents used are as follows: XAV-939 (Selleck), BIO (Cayman Chemical), TGFb1 (Sigma or StemRD), mouse TGFb2 (Sigma), mouse Wnt3a (R&D or StemRD), mouse Wnt5a (R&D), DMSO (Sigma), ALK5 inhibitor II (Calbiochem), TGFb2-specific blocking antibody (AB-12-NA, R&D), and rabbit IgG (R&D).
Microarrays
Primary myoblasts isolated from newborn mice were treated for 4 hours in DMEM with 2% HS in the presence or in the absence of Wnt3a (100 ng/ml). RNA was assayed by Affymetrix Mouse 430 2.0 Genome Array.
Transfection
Primary and C2C12 myoblasts were transfected with Lipofectamine 2000 (Invitrogen). Vectors used were mouse TGFb2 (ATCC, MGC-18603), E[beta]C (28) (Addgene), pLVX-EF1alpha-IRES-mCherry (Clontech), nGFP (90), B9L, and B9LDCter (29) . Two days after transfection, cells were trypsinized and purified according to mCherry expression by FACS. DAPI dilactate (250 mg/ml) was used to exclude dead cells.
Western blots
Muscle homogenates were centrifuged, and the protein content of the supernatant was quantified using BCA Protein Assay Kit (Pierce). Equal amounts of protein (50 mg) were separated on 8% SDS-polyacrylamide gel electrophoresis gels and transferred to nitrocellulose membranes (GE). The membranes were stained with Ponceau S to confirm the protein amount and incubated overnight at 4°C with mouse primary antibodies recognizing active b-catenin (Millipore) and TGFb2 (Abcam). Membranes were incubated with secondary antibodies for 60 min at room temperature, and signals were detected with a ChemiDoc XRS+ Molecular Imager (Bio-Rad) using ECL detection reagents (Amersham).
Statistical analysis
Data are presented as means ± SE. Unless otherwise stated, unpaired one-tailed t tests were used to calculate the statistical significance of observed differences.
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